Capitol Health Limited provides diagnostic imaging and related services to the healthcare market in Australia. More Details
Reasonable growth potential with adequate balance sheet.
Share Price & News
How has Capitol Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CAJ is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: CAJ's weekly volatility (5%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: CAJ exceeded the Australian Healthcare industry which returned 0.2% over the past year.
Return vs Market: CAJ exceeded the Australian Market which returned -1.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Capitol Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StHere's Why Capitol Health (ASX:CAJ) Can Manage Its Debt Responsibly
1 month ago | Simply Wall StCapitol Health's (ASX:CAJ) Shareholders Are Down 55% On Their Shares
1 month ago | Simply Wall StHave Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?
Is Capitol Health undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CAJ (A$0.28) is trading above our estimate of fair value (A$0.17)
Significantly Below Fair Value: CAJ is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CAJ is poor value based on its PE Ratio (263.4x) compared to the AU Healthcare industry average (30.5x).
PE vs Market: CAJ is poor value based on its PE Ratio (263.4x) compared to the Australian market (22.4x).
Price to Earnings Growth Ratio
PEG Ratio: CAJ is poor value based on its PEG Ratio (5.7x)
Price to Book Ratio
PB vs Industry: CAJ is overvalued based on its PB Ratio (2x) compared to the AU Healthcare industry average (1.8x).
How is Capitol Health forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CAJ's forecast earnings growth (46% per year) is above the savings rate (2.3%).
Earnings vs Market: CAJ's earnings (46% per year) are forecast to grow faster than the Australian market (17.9% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CAJ's revenue (9% per year) is forecast to grow faster than the Australian market (5.1% per year).
High Growth Revenue: CAJ's revenue (9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CAJ's Return on Equity is forecast to be low in 3 years time (11.2%).
How has Capitol Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CAJ has a large one-off loss of A$10.5M impacting its June 30 2020 financial results.
Growing Profit Margin: CAJ's current net profit margins (0.6%) are lower than last year (16.3%).
Past Earnings Growth Analysis
Earnings Trend: CAJ's earnings have grown significantly by 34.6% per year over the past 5 years.
Accelerating Growth: CAJ's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CAJ had negative earnings growth (-96.4%) over the past year, making it difficult to compare to the Healthcare industry average (-8.1%).
Return on Equity
High ROE: CAJ's Return on Equity (0.8%) is considered low.
How is Capitol Health's financial position?
Financial Position Analysis
Short Term Liabilities: CAJ's short term assets (A$20.3M) do not cover its short term liabilities (A$40.2M).
Long Term Liabilities: CAJ's short term assets (A$20.3M) do not cover its long term liabilities (A$78.1M).
Debt to Equity History and Analysis
Debt Level: CAJ's debt to equity ratio (11.8%) is considered satisfactory.
Reducing Debt: CAJ's debt to equity ratio has reduced from 72.1% to 11.8% over the past 5 years.
Debt Coverage: CAJ's debt is well covered by operating cash flow (205.9%).
Interest Coverage: CAJ's interest payments on its debt are well covered by EBIT (4.3x coverage).
What is Capitol Health current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CAJ's dividend (3.57%) is higher than the bottom 25% of dividend payers in the Australian market (2.14%).
High Dividend: CAJ's dividend (3.57%) is low compared to the top 25% of dividend payers in the Australian market (5.1%).
Stability and Growth of Payments
Stable Dividend: CAJ has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: CAJ's dividend payments have increased, but the company has only paid a dividend for 9 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (940.7%), CAJ's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CAJ's dividends in 3 years are forecast to be covered by earnings (63% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Justin Samuel Walter, MPH (JCU) has been the Chief Executive Officer, Managing Director and a Director at Capitol Health Limited since July 1, 2019 and was its Chief Operating Officer since 2019 until ...
CEO Compensation Analysis
Compensation vs Market: Justin's total compensation ($USD937.81K) is above average for companies of similar size in the Australian market ($USD529.04K).
Compensation vs Earnings: Justin's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
|CEO, MD & Director||1.33yrs||AU$1.28m||no data|
|Non-Executive Chairman||6yrs||AU$238.75k||0.020% |
|Non-Executive Director||4.92yrs||AU$91.61k||no data|
|Independent Non-Executive Director||3.17yrs||AU$102.69k||0.064% |
Experienced Board: CAJ's board of directors are considered experienced (4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.4%.
Capitol Health Limited's company bio, employee growth, exchange listings and data sources
- Name: Capitol Health Limited
- Ticker: CAJ
- Exchange: ASX
- Founded: 2005
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: AU$287.028m
- Shares outstanding: 1.03b
- Website: https://www.capitolhealth.com.au
- Capitol Health Limited
- 288 Victoria Parade
- Level 2
- East Melbourne
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CAJ||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Jun 2006|
|CAJ||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Jun 2006|
|D4I||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jun 2006|
Capitol Health Limited provides diagnostic imaging and related services to the healthcare market in Australia. The company owns and operates clinics in Victoria, Tasmania, and Western Australia. It offers ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/11/23 10:39|
|End of Day Share Price||2020/11/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.